Literature DB >> 2837832

Therapy of small cell lung cancer: a perspective on two decades of clinical research.

E J Seifter1, D C Ihde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2837832

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  18 in total

Review 1.  Extrapulmonary small cell carcinoma.

Authors:  J A Ledermann
Journal:  Postgrad Med J       Date:  1992-02       Impact factor: 2.401

Review 2.  Chemotherapy advances in small-cell lung cancer.

Authors:  Bryan A Chan; Jermaine I G Coward
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

3.  Small cell lung cancer.

Authors:  G Crompton
Journal:  BMJ       Date:  1990-01-27

4.  Small cell carcinoma of the bronchus: historical perspective of a treatable disease.

Authors:  S W Watkin; J A Green
Journal:  J R Soc Med       Date:  1990-02       Impact factor: 5.344

Review 5.  A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy.

Authors:  R Abraham; R L Basser; M D Green
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

6.  The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients.

Authors:  Shaodong Hong; Ting Zhou; Wenfeng Fang; Cong Xue; Zhihuang Hu; Tao Qin; Yanna Tang; Yue Chen; Yuxiang Ma; Yunpeng Yang; Xue Hou; Yan Huang; Hongyun Zhao; Yuanyuan Zhao; Li Zhang
Journal:  Tumour Biol       Date:  2014-12-20

7.  Effect of cigarette smoking on quality of life in small cell lung cancer patients.

Authors:  Jun Chen; Yingwei Qi; Jason A Wampfler; Aminah Jatoi; Yolanda I Garces; Allan J Busta; Sumithra J Mandrekar; Ping Yang
Journal:  Eur J Cancer       Date:  2012-01-12       Impact factor: 9.162

8.  Prognosis of common cancers.

Authors:  P H Geggie
Journal:  Can Fam Physician       Date:  1990-05       Impact factor: 3.275

9.  Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer.

Authors:  Neelesh Sharma; Nathan Pennell; Myles Nickolich; Balazs Halmos; Patrick Ma; Tarek Mekhail; Pingfu Fu; Afshin Dowlati
Journal:  Invest New Drugs       Date:  2014-01-15       Impact factor: 3.850

10.  Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.

Authors:  Caroline Dive; Christopher J Morrow; Radosław Polański; Cassandra L Hodgkinson; Alberto Fusi; Daisuke Nonaka; Lynsey Priest; Paul Kelly; Francesca Trapani; Paul W Bishop; Anne White; Susan E Critchlow; Paul D Smith; Fiona Blackhall
Journal:  Clin Cancer Res       Date:  2013-11-25       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.